...
首页> 外文期刊>Diagnostic microbiology and infectious disease >Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-γ
【24h】

Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-γ

机译:脂质体两性霉素B,伏立康唑和重组干扰素-γ联合成功治疗顽固性HIV相关性隐球菌性脑膜炎

获取原文
获取原文并翻译 | 示例
           

摘要

We present 2 cases of HIV-related cryptococcal meningitis, persisting after 3 and 9 months, respectively, of standard treatment. Both patients were treated successfully with a salvage regimen consisting of the combination of liposomal amphotericin B (3 mg/kg), intravenous voriconazole, and subcutaneous recombinant interferon γ-1b (200 μg thrice weekly). Voriconazole was administered at an increased dose (5 mg/kg, twice daily) to overcome interactions with co-administered ritonavir. In both patients, resolution of clinical signs and symptoms, as well as sterilization of cerebrospinal fluid cultures occurred after 10 weeks of salvage therapy. No major side effects were encountered. At the end of treatment, both patients were placed on maintenance therapy with oral fluconazole; no recurrence has been observed after 4 years of follow-up.
机译:我们目前有2例HIV相关隐球菌性脑膜炎,分别在3个月和9个月的标准治疗后持续存在。两名患者均成功接受了由脂质体两性霉素B(3 mg / kg),静脉伏立康唑和皮下重组干扰素γ-1b(每周200μg)组成的挽救方案。伏立康唑以增加的剂量(5 mg / kg,每天两次)给药,以克服与共同给药的利托那韦的相互作用。在这两名患者中,挽救治疗10周后均出现了临床症状和体征的消退以及脑脊液培养物的灭菌。没有遇到重大的副作用。在治疗结束时,两名患者均接受口服氟康唑维持治疗。随访4年后未观察到复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号